Clinical Trial Update: A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. [Phase 1]

View source ↗

Summary

Phase 1 study comparing three formulations of tamsulosin at steady state has completed in benign prostatic hyperplasia. The sponsor is GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 1 | Status: COMPLETED